|
RAB3GAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.160600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.070420E-01 |
| Normal-vs-Stage2 |
9.771600E-01 |
| Normal-vs-Stage3 |
7.675600E-01 |
| Normal-vs-Stage4 |
8.828400E-01 |
| Stage1-vs-Stage2 |
4.858600E-01 |
| Stage1-vs-Stage3 |
2.747400E-01 |
| Stage1-vs-Stage4 |
6.903600E-01 |
| Stage2-vs-Stage3 |
8.206400E-01 |
| Stage2-vs-Stage4 |
9.130000E-01 |
| Stage3-vs-Stage4 |
7.665400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.250800E-01 |
| Normal-vs-AfricanAmerican |
6.836000E-01 |
| Normal-vs-Asian |
5.528400E-01 |
| Caucasian-vs-AfricanAmerican |
9.287800E-01 |
| Caucasian-vs-Asian |
4.843000E-01 |
| AfricanAmerican-vs-Asian |
5.360600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.758400E-02 |
| Normal-vs-Female |
4.407700E-02 |
| Male-vs-Female |
1.499650E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.330300E-02 |
| Normal-vs-Extreme_Weight |
2.304000E-02 |
| Normal-vs-Obese |
5.705000E-01 |
| Normal-vs-Extreme_Obese |
4.943600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.674200E-01 |
| Normal_Weight-vs-Obese |
5.821500E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.347400E-01 |
| Extreme_Weight-vs-Obese |
2.944300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.481800E-01 |
| Obese-vs-Extreme_Obese |
3.743600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.336250E-01 |
| Normal-vs-Age(41-60Yrs) |
3.106800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.018400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.271600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.045200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.401680E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.242300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.781800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.999570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.151400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.920600E-01 |
| Normal-VS-Type2 PRCC |
8.312400E-02 |
| Normal-VS-KIRP CIMP |
6.290200E-02 |
| Normal-VS-Unclassified PRCC |
2.688400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.992000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.008150E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.182020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.759790E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.356000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.003600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.065800E-02 |
| Normal-vs-N1 |
1.935030E-01 |
| Normal-vs-N2 |
3.009000E-01 |
| N0-vs-N1 |
1.504460E-02 |
| N0-vs-N2 |
2.881800E-01 |
| N1-vs-N2 |
8.326400E-01 |
|
|
